Slow onset of CNS drugs: can changes in protein concentration account for the delay?

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.9, 2001-09, pp. : 450-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

By Lockwood Peter Ewy Wayne Hermann David Holford Nick

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2050-2059

Springer Publishing Company

Access to resources Recommend Favorite

CNS Drugs III: Psychotherapeutics

By Marsden C.A. Stanford S.C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1923-1929

Informa Healthcare

Access to resources Recommend Favorite

Age-Related Changes in Protein Binding of Drugs: Implications for Therapy

By Grandison M.K. Boudinot F.D.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 271-290

Adis International

Access to resources Recommend Favorite

Emerging drugs for partial onset seizures

By Nasreddine Wassim Beydoun Ahmad Atweh Samir Abou-Khalil Bassel

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 415-431

Informa Healthcare

Access to resources Recommend Favorite

Fluorinated Molecules as Drugs and Imaging Agents in the CNS

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 14, 2006-07 ,pp. : 1457-1464

Bentham Science Publishers

Access to resources Recommend Favorite